Industrial Scale Microbiome Mining is a New Drug Discovery Toolbox
Within ten years of execution and widespread adoption, most pipelines will be traced to the opportunity of untapped microbes of the earth.
Ross Youngs
Ross Youngs is an environmental scientist and CEO and Co-Founder of Biosortia Microbiomics, a company dedicated to microbiome mining for pharmaceutical discovery. Young’s recent major innovations include an R&D 100 Award for collaboration on biopolymer technologies. In 2009, Biosortia was awarded a $6 million ARPA-E (U.S. Dept. of Energy R&D) grant for its algal harvesting technology, which helped lead to the development of Biosortia’s drug discovery platform.